Login / Signup

Trends in actual medication use for child-onset systemic lupus erythematosus using the Japanese health insurance database 2009-18.

Takayuki KishiRyoko SakaiYumi TaniSatoru NagataYasuhiro KatsumataTakako MiyamaeMasayoshi Harigai
Published in: Modern rheumatology (2022)
Oral prednisolone was the mainstay of treatment for cSLE, and the maximum daily dose has reduced over the past decade. The most frequently prescribed immunosuppressive therapy has shifted to mycophenolate mofetil over time.
Keyphrases